GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » PS Ratio

MedMen Enterprises (MedMen Enterprises) PS Ratio : 0.00 (As of May. 31, 2024)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, MedMen Enterprises's share price is $0.0001. MedMen Enterprises's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $0.09. Hence, MedMen Enterprises's PS Ratio for today is 0.00.

The historical rank and industry rank for MedMen Enterprises's PS Ratio or its related term are showing as below:

MMNFQ's PS Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.165
* Ranked among companies with meaningful PS Ratio only.

MedMen Enterprises's Revenue per Sharefor the three months ended in Mar. 2023 was $0.02. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $0.09.

Back to Basics: PS Ratio


MedMen Enterprises PS Ratio Historical Data

The historical data trend for MedMen Enterprises's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises PS Ratio Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.38 2.27 0.39 0.89 0.51

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 0.51 0.36 0.15 0.16

Competitive Comparison of MedMen Enterprises's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's PS Ratio distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's PS Ratio falls into.



MedMen Enterprises PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

MedMen Enterprises's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.0001/0.092
=0.00

MedMen Enterprises's Share Price of today is $0.0001.
MedMen Enterprises's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


MedMen Enterprises  (OTCPK:MMNFQ) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


MedMen Enterprises PS Ratio Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises (MedMen Enterprises) Headlines

From GuruFocus

MedMen Provides Annual Filing Status Report

By Business Wire 11-30-2023

Q4 2021 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2021 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2019 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

MedMen Completes Sale of Florida Assets

By Business Wire Business Wire 08-22-2022

Q2 2020 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024